543960:BOM
Concord Biotech Ltd
₹1,339.85
arrow_downward
-0.99%(-13.40) 1D
Okt 16, 3:30:00 PM GMT+5:30 · INR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa 543960...
Buksan
₹1,355.00
Mataas
₹1,355.95
Mababa
₹1,333.00
Mkt. cap
140.34B
Avg. na dami
10.10K
Dami
1.27K
Dividend
0.56%
Bawat tatlong buwang dividend
₹1.89
Petsa ng ex-dividend
Hul 24, 2026
P/E ratio
50.93
Mataas nang 52-wk
₹1,614.05
Mababa nang 52-wk
₹987.05
EPS
₹26.31
Bilang ng mga empleyado
2K
Buksan
₹1,355.00
Mataas
₹1,355.95
Mababa
₹1,333.00
Mkt. cap
140.34B
Avg. na dami
10.10K
Dami
1.27K
Dividend
0.56%
Bawat tatlong buwang dividend
₹1.89
Petsa ng ex-dividend
Hul 24, 2026
P/E ratio
50.93
Mataas nang 52-wk
₹1,614.05
Mababa nang 52-wk
₹987.05
EPS
₹26.31
Bilang ng mga empleyado
2K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
GlobeNewswire
·
46 minuto ang nakalipas
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight
Business Wire
·
1 oras ang nakalipas
Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: FFR to Hold Listing Ceremony and First Investor Day at the Nasdaq Tower on Oct. 26; Three New Robotics Product Offerings Launched
marketscreener.com
·
10 minuto ang nakalipas
CECO Environmental Corp. Primary Exchange Listing will Change to Texas Stock Exchange from Nasdaq Global Select
Bloomberg.com
·
2 oras ang nakalipas
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profile
Concord Biotech Limited is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation-based biopharmaceutical active pharmaceutical ingredients sold worldwide.
It manufactures biopharmaceutical products across therapy segments such as immunosuppressant, oncology, antifungal, antibacterial and anthelmintic. It has two manufacturing facilities–at Dholka near Ahmedabad, which is approved by USFDA, and at Limbasi in Kheda district. Wikipedia
Tungkol sa Concord Biotech Ltd